Figure 1 Flowchart illustrating numbers of cases evaluated at each stage of study. SADS, sudden arrhythmic death ... Figure 1 Flowchart illustrating numbers.

Slides:

Advertisements

Similar presentations

Figure 1 Rates of complications and mortality during index admission for atrial fibrillation ablation for the overall ... Figure 1 Rates of complications.

Advertisements

Figure 1 Periprocedural myonecrosis and myocardial infarction after left main coronary artery revascularization with ... Figure 1 Periprocedural myonecrosis.

Figure 1 Subject phenotypes and most common genotype in subjects enrolled in THAOS in continental Western Europe. Data ... Figure 1 Subject phenotypes.

Figure 1 Study flow diagram and definition of clinical response

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 Data-selection process

Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Multivariable-adjusted predictors of PAC

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.

Figure 1 Mechanism of mortality benefit associated with radial access

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.

Figure 1 Phases of the research. Author’s own work.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

AHA: American Heart Association; ALT: ...

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.

Source: Figure created by the author based on data ...

bDMARD: biologic DMARD.

Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

RCTs: randomized controlled ...

Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.

Take home figure The protective role of CNP/NPR-B/NPRC.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Fig. 1. A flowchart of cohort participants screened, enrolled and followed-up between 1 July 2015 and 31 May Fig. 1. A flowchart of cohort participants.

Figure 1 Representative examples of three-dimensional volume-rendered CT images of AOLCA (A) and AORCA (B) with an IAC ... Figure 1 Representative examples.

Fig. 1 Subacute cutaneous lupus erythematous at the lower limbs

Fig. 1 Flow chart of included patients for analyses

Fig. 1 Flow chart for selection of study subjects

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Selection algorithm of patients being included in the German Aortic Valve Registry in 2014 and Figure 1 Selection algorithm of patients.

Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Relationships between pair indices of dance performance (joint entropy or mutual information) and the past ... Figure 1 Relationships between.

Figure 1 Immunohistochemistry for human cell differentiation molecules in samples of the right ventricular septum from ... Figure 1 Immunohistochemistry.

Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

(A) Hypoechoic ‘halo sign’ of ...

Figure Ranking of Cardiovascular Journals as published by Clarivate Analytics. Unless provided in the caption above, the following copyright applies.

(A) Funduscopy showed retinal haemorrhages (black arrows), retinal exudates ... (A) Funduscopy showed retinal haemorrhages (black arrows), retinal exudates.

Figure 1. Trunk and leg fat over study period. LS, log transformed.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Take home figure Proposed mechanisms of Staphylococcus aureus endocarditis. CVC, central venous catheter; IV, intravenous; S. ... Take home figure Proposed.

Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.

Figure 1. Oncoprint of selected pathogenic alterations detected in ctDNA. Unless provided in the caption above, the following copyright applies to the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 Patient selection

Fig. 1 A network representation of top 100 co-occurring terms

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Fig. 1 Statistics of the main characters’ dialogues.

Figure 1 Patient selection.

Figure 1 Grant agencies and charitable foundations supporting Plan S.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Fig. 1 Schematic subcategorization of AAV in three clinically relevant disease categories defined by clinical ... Fig. 1 Schematic subcategorization of.

Figure 3. Key words and phrases from narrative text by classification category. Unless provided in the caption above, the following copyright applies to.

Figure 1 Mechanisms of mitral regurgitation.

Figure 1 The picture shows the three different procedures, all performed through transseptal access and using an ... Figure 1 The picture shows the three.

Figure 1: Trade shares of South Korea's major trading partners (% of South Korea's total trade in goods) Figure 1: Trade shares of South Korea's major.

Figure 1 ABCDE of primary prevention.2

Figure 1. Forest plot of lung cancer mortality in LDCT trials.

Figure 1. Evolutionary process of a policy field.

Table 2. Mean noise level results for hand dryers in dBA

Presentation transcript:

Figure 1 Flowchart illustrating numbers of cases evaluated at each stage of study. SADS, sudden arrhythmic death ... Figure 1 Flowchart illustrating numbers of cases evaluated at each stage of study. SADS, sudden arrhythmic death syndrome; SCD, sudden cardiac death; SUD, sudden unexplained death; SUDEP, sudden unexplained death in epilepsy; RMH, Royal Melbourne Hospital; VIFM, Victorian Institute of Forensic Medicine. Key: *Includes five cases without coronial permission to refer. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) European Heart Journal, Volume 40, Issue 10, 30 October 2018, Pages 831–838, https://doi.org/10.1093/eurheartj/ehy654 The content of this slide may be subject to copyright: please see the slide notes for details.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) European Heart Journal, Volume 40, Issue 10, 30 October 2018, Pages 831–838, https://doi.org/10.1093/eurheartj/ehy654 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 2 Uncertain autopsy findings identified following unexplained sudden cardiac death and associated cardiogenetic ... Figure 2 Uncertain autopsy findings identified following unexplained sudden cardiac death and associated cardiogenetic clinical phenotypes identified in blood relatives. BrS, Brugada syndrome; DCM, dilated cardiomyopathy; FMD, fibromuscular dysplasia of coronary/AV nodal arteries; LV, left ventricular; LQT, long QT syndrome; SUD, sudden unexplained death; RV, right ventricular. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) European Heart Journal, Volume 40, Issue 10, 30 October 2018, Pages 831–838, https://doi.org/10.1093/eurheartj/ehy654 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 3 Histogram of number of uncertain cardiac autopsy findings per case identified in unexplained sudden cardiac ... Figure 3 Histogram of number of uncertain cardiac autopsy findings per case identified in unexplained sudden cardiac death (SCD, blue) probands and non-cardiac premature deaths (control, green). Significantly more unexplained SCD cases with ≥1 uncertain finding (P < 0.001). Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) European Heart Journal, Volume 40, Issue 10, 30 October 2018, Pages 831–838, https://doi.org/10.1093/eurheartj/ehy654 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 4 Diagnostic yield of cardiogenetic disease following cardiological evaluation of blood relatives of ... Figure 4 Diagnostic yield of cardiogenetic disease following cardiological evaluation of blood relatives of unexplained sudden cardiac death probands with normal (left; true SADS) and non-diagnostic (right; uncertain SUD) cardiac autopsy findings. No significant difference between proportions identified with cardiogenetic disease (P = 0.34). BrS, Brugada syndrome; DCM, dilated cardiomyopathy; LQT, long QT syndrome; PCCD, progressive cardiac conduction disease; SADS, sudden arrhythmic death syndrome; SQT, short QT syndrome; SUD, sudden unexplained death. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) European Heart Journal, Volume 40, Issue 10, 30 October 2018, Pages 831–838, https://doi.org/10.1093/eurheartj/ehy654 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 5 Examples of uncertain histological findings identified in sudden unexplained death (SUD) cases (haematoxylin ... Figure 5 Examples of uncertain histological findings identified in sudden unexplained death (SUD) cases (haematoxylin and eosin stained sections): (A) myocardial hypertrophy and pericellular fibrosis in the septum centrally (×10 magnification), identified in a family with no definite cardiogenetic disease; (B) fat infiltration and replacement fibrosis in the right ventricle (×2 magnification) insufficient to meet minor criteria for arrhythmogenic cardiomyopathy diagnosis, identified in a family with Brugada syndrome; (C) moderate left anterior descending coronary artery stenosis (assessed as 60% stenosis in a collapsed artery that was macroscopically patent prior to histological slide creation) due to soft plaque (main image ×2 magnification) in a 35-year-old, also associated with a distal intramyocardial course (inset image ×10 magnification), identified in a family with dilated cardiomyopathy; (D) myxoid mitral valve degeneration (main image ×2 and inset image ×10 magnification), identified in a family with long QT syndrome. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) European Heart Journal, Volume 40, Issue 10, 30 October 2018, Pages 831–838, https://doi.org/10.1093/eurheartj/ehy654 The content of this slide may be subject to copyright: please see the slide notes for details.

Take home figure Risk factors for unexplained sudden cardiac death: cardiogenetic diseases and uncertain cardiac histological ... Take home figure Risk factors for unexplained sudden cardiac death: cardiogenetic diseases and uncertain cardiac histological characteristics are both implicated. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) European Heart Journal, Volume 40, Issue 10, 30 October 2018, Pages 831–838, https://doi.org/10.1093/eurheartj/ehy654 The content of this slide may be subject to copyright: please see the slide notes for details.